Prenatal detection of heart defects in a non-selected population of 30149 fetuses - Detection rates and outcome

Ultrasound in Obstetrics and Gynecology

Volumn 27, Issue 3, 2006, Pages 252-265

  Tegnander, E ^a   Williams, W ^a   Johansens, O J ^a   Blaas, H G K ^a   Eik Nes, S H ^a  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

Congenital heart defects; Detection rates; Fetus; Incidence; Outcome; Prenatal ultrasound

Indexed keywords

ARTICLE; CHROMOSOME ABERRATION; CLINICAL TRIAL; CONGENITAL HEART MALFORMATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FETUS; FETUS DEATH; FETUS ECHOGRAPHY; FETUS MONITORING; FOLLOW UP; GESTATIONAL AGE; GREAT BLOOD VESSEL; HUMAN; KARYOTYPE; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN MORTALITY; OUTCOME ASSESSMENT; PERINATAL PERIOD; POPULATION DENSITY; PREGNANCY TERMINATION; PRENATAL DIAGNOSIS; PRENATAL PERIOD; PRIORITY JOURNAL;

ADOLESCENT; ADULT; CHROMOSOME ABERRATIONS; FEMALE; FETUS; FOLLOW-UP STUDIES; HEART DEFECTS, CONGENITAL; HUMANS; INFANT MORTALITY; INFANT, NEWBORN; MALE; MIDDLE AGED; PREGNANCY; PREGNANCY OUTCOME; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, PRENATAL;

EID: 33646684079     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.2710     Document Type: Article

References (64)

1. Fermont L, deGeeter B, Aubry MC, Kachaner J, Sidi D. A close collaboration between obstetricians and pediatric cardiologists allows antenatal detection of severe cardiac malformations by 2D echocardiography (Abstract). Proceedings of the 2nd World Congress of Paediatric Cardiology, New York, 1985; 10.
2. Allan LD, Crawford DC, Chita SK, Tynan MJ. Prenatal screening for congenital heart disease. BMJ 1986; 292: 1717-1719.
3. Bonnet D, Coltri A, Butera G, Ferment L, Le Bidois J, Kachaner J, Sidi D. Detection of transposition of the great arteries in fetuses reduces neonatal morbidity and mortality. Circulation 1999; 99: 916-918.
4. Tworetzky W, McElhinney D, Reddy VM, Brook MM, Hanley FL, Silverman NH. Improved surgical outcome after fetal diagnosis of hypoplastic left heart syndrome. Circulation 2001; 103: 1269-1273.
5. Allan LD, Sharland G, Milburn A, Lockhart SM, Groves AMM, Anderson RH, Cook AC, Fagg NLK. Prospective diagnosis of 1,006 consecutive cases of congenital heart disease in the fetus. J Am Coll Cardiol 1994; 23: 1452-1458.
6. Carvalho JS, Mavrides E, Shinebourne EA, Campbell S, Thilaganathan B. Improving the effectiveness of routine prenatal screening for major congenital heart defects. Heart 2002; 88: 387-391.
7. Sharland G. Routine fetal cardiac screening: what are we doing and what should we do? Prenat Diagn 2004; 24: 1123-1129.
8. Chaoui R. The four-chamber view: four reasons why it seems to fail in screening for cardiac abnormalities and suggestions to improve detection rate. Ultrasound Obstet Gynecol 2003; 22: 3-10.
9. Allan LD. Cardiac anatomy screening: what is the best time for screening in pregnancy? Curr Opin Obstet Gynecol 2003; 15: 143-146.
10. Backe B. Routine use of ultrasound in obstetrics in Norway, 1994. Tidsskr Nor Lægeforen 1997; 117: 2314-2315.
11. Wakui K, Tanemura M, Suzumori K, Hidaka E, Ishikawa M, Kubota T, Fukushima Y. Clinical applications of two-color telomeric fluorescence in situ hybridization for prenatal diagnosis: Identification of chromosomal translocation in five families with recurrent miscarriages or a child with multiple congenital anomalies. J Hum Genet 1999; 44: 85-90.
12. Isaksen CV, Eik-Nes SH, Blaas H-G, Tegnander E, Torp SH. Comparison of prenatal ultrasound and postmortem findings in fetuses and infants with congenital heart defects. Ultrasound Obstet Gynecol 1999; 13: 117-126.
13. Mitchell SC, Korones SB, Berendes HW. Congenital heart disease in 56,109 births. Incidence and natural history. Circulation 1971; 43: 323-332.
14. American Heart Association: 1994 Revisions to classification of functional capacity and objective assessment of patients with diseases of the heart. http://www.americanheart.org/presenter. jhtml?identifier=1712 [Accessed 11 February 2005].
15. Tegnander E, Eik-Nes SH, Johansen OJ, Linker DT. Prenatal detection of heart defects at the routine fetal examination at 18 weeks in a non-selected population. Ultrasound Obstet Gynecol 1995; 5: 372-380.
16. Rustico MA, Benettoni A, D'Ottavio G, Maieron A, Fischer-Tamaro I, Conoscenti G, Meir Y, Montesano M, Cattaneo A, Mandruzzato G. Fetal heart screening in low-risk pregnancies. Ultrasound Obstet Gynecol 1995; 6: 313-319.
17. Bromley B, Estroff JA, Sanders SP, Parad R, Roberts D, Frigoletto Jr FD, Benacerraf BR. Fetal echocardiography: Accuracy and limitations in a population at high and low risk for heart defects. Am J Obstet Gynecol 1992; 166: 1473-1481.
18. Hafner E, Scholler J, Schuchter K, Sterniste W, Philipp K. Detection of fetal congenital heart disease in a low-risk population. Prenat Diagn 1998; 18: 808-815.
19. Stoll C, Alembik Y, Dott B, Meyer MJ, Pennerath A, Peter MO, De Geeter B. Evaluation of prenatal diagnosis of congenital heart disease. Prenat Diagn 1998; 18: 801-807.
20. Boldt T, Andersson S, Eronen M. Outcome of structural heart disease diagnosed in utero. Scand Cardiovasc J 2002; 36: 73-79.
21. Brick DH, Allan LD. Outcome of prenatally diagnosed congenital heart disease: An update. Pediatr Cardiol 2002; 23: 449-453.
22. Wong SF, Chan FY, Cincotta RB, Lee-Tannock A, Ward C. Factors influencing the prenatal detection of structural congenital heart diseases. Ultrasound Obstet Gynecol 2003; 21: 19-25.
23. Levi S. Mass screening for fetal malformations: the Eurofetus study. Ultrasound Obstet Gynecol 2003; 22: 555-558.
24. Garne E, Stoll C, Clementi M, The Euroscan Group. Evaluation of prenatal diagnosis of congenital heart diseases by ultrasound: experience from 20 European registries. Ultrasound Obstet Gynecol 2001; 17: 386-391.
25. Stoll C, Dott B, Alembik Y, De Geeter B. Evaluation and evolution during time of prenatal diagnosis of congenital heart diseases by routine fetal ultrasonographic examination. Ann Genet 2002; 45: 21-27.
26. Kirk JS, Comstock CH, Lee W, Smith RS, Riggs TW, Weinhouse E. Sonographic screening to detect fetal cardiac anomalies: A 5-year experience with 111 abnormal cases. Obstet Gynecol 1997; 89: 227-232.
27. Levi S, Zhang WH, Alexander S, Viart P, Grandjean H and the Eurofetus Study Group. Short-term outcome of isolated and associated congenital heart defects in relation to antenatal ultrasound screening. Ultrasound Obstet Gynecol 2003; 21: 532-538.
28. Nicolaides KH, Azar G, Byrne D, Mansur C, Marks K. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. BMJ 1992; 304: 867-869.
29. Schwärzler P, Carvalho JS, Senat M-V, Masroor T, Campbell S, Ville Y. Screening for fetal aneuploidies and fetal cardiac abnormalities by nuchal translucency thickness measurement at 10-14 weeks of gestation as part of routine antenatal care in an unselected population. Br J Obstet Gynaecol 1999; 106: 1029-1034.
30. Hyett JA, Perdu M, Sharland GK, Snijders RJM, Nicolaides KH. Increased nuchal translucency at 10-14 weeks of gestation as a marker for major cardiac defects. Ultrasound Obstet Gynecol 1997; 10: 242-246.
31. Hyett J, Perdu M, Sharland G, Snijders R, Nicolaides KH. Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study. BMJ 1999; 318: 81-85.
32. Haak MC, Bartelings MM, Gittenberger-de Groot AC, Van Vugt JMG. Cardiac malformations in first-trimester fetuses with increased nuchal translucency: ultrasound diagnosis and postmortem morphology. Ultrasound Obstet Gynecol 2002; 20: 14-21.
33. Hafner E, Schuchter K, Liebhart E, Philipp K. Results of routine fetal nuchal translucency measurements at weeks 10-13 in 4233 unselected pregnant women. Prenat Diagn 1998; 18: 29-34.
34. Allan LD. Development of congenital lesions in mid or late gestation. Int J Cardiol 1988; 19: 361-362.
35. Yagel S, Weissman A, Rotstein Z, Manor M, Hegesh J, Anteby E, Lipitz S, Achiron R. Congenital Heart Defects. Natural course and in utero development. Circulation 1997; 96: 550-555.
36. Maeno Y, Himeno W, Fujino H, Sugahara Y, Furui J, Mizumoto Y, Kato H. Progression of congenital heart disease in the prenatal period. Pediatr Int 1999; 41: 709-715.
37. Hunter S, Heads A, Wyllie J, Robson S. Prenatal diagnosis of congenital heart disease in the northern region of England: benefits of a training programme for obstetric ultrasonographers. Heart 2000; 84: 294-298.
38. Achiron R, Glaser J, Gelernter I, Hegesh J, Yagel S. Extended fetal echocardiographic examination for detecting cardiac malformations in low risk pregnancies. BMJ 1992; 304: 671-674.
39. Schwärzler P, Senat M-V, Holden D, Bernard JP, Masroor T, Ville Y. Feasibility of the second-trimester fetal ultrasound examination in an unselected population at 18, 20 or 22 weeks of pregnancy: a randomized trial. Ultrasound Obstet Gynecol 1999; 14: 92-97.
40. Yoo S-J, Lee Y-H, Kim ES, Ryu HM, Kim MY, Choi H-K, Cho KS, Kim A. Three-vessel view of the fetal upper mediastinum: an easy means of detecting abnormalities of the ventricular outflow tracts and great arteries during obstetric screening. Ultrasound Obstet Gynecol 1997; 9: 173-182.
41. Chaoui R, McEwing R. Three cross-sectional planes for fetal color Doppler echocardiography. Ultrasound Obstet Gynecol 2003; 21: 81-93.
42. Yoo S-J, Lee YH, Cho KS. Abnormal three-vessel view on sonography: A clue to the diagnosis of congenital heart disease in the fetus. AJR Am J Roentgenol 1999; 172: 825-830.
43. Bull C. Current and potential impact of fetal diagnosis on prevalence and spectrum of serious congenital heart disease at term in the UK. Lancet 1999; 354: 1242-1247.
44. Copel JA, Cullen M, Green JJ, Mahoney MJ, Hobbins JC, Kleinman CS. The frequency of aneuploidy in prenatally diagnosed congenital heart disease: An indication for fetal karyotyping. Am J Obstet Gynecol 1988; 158: 409-413.
45. Berg KA, Clark EB, Astemborski JA, Boughman JA. Prenatal detection of cardiovascular malformations by echocardiography: An indication for cytogenetic evaluation. Am J Obstet Gynecol 1988; 159: 477-481.
46. Boudjemline Y, Fermont L, Le Bidois J, Lyonnet S, Sidi D, Bonnet D. Prevalence of 22q11 deletion in fetuses with conotruncal cardiac defects: A 6-year prospective study. J Pediatr 2001; 138: 520-524.
47. Fesslova V, Nava S, Villa L and the Fetal Cardiology Study Group of the Italian Society of Pediatric Cardiology. Evolution and long term outcome in cases with fetal diagnosis of congenital heart disease: Italian multicentre study. Heart 1999; 82: 594-599.
48. Allan LD, Huggon IC. Counselling following a diagnosis of congenital heart disease. Prenat Diagn 2004; 24: 1136-1142.
49. Crawford DC, Chita SK, Allan LD. Prenatal detection of congenital heart disease: Factors affecting obstetric management and survival. Am J Obstet Gynecol 1988; 159: 352-356.
50. Franklin O, Burch M, Manning N, Sleeman K, Gould S, Archer N. Prenatal diagnosis of coarctation of the aorta improves survival and reduces morbidity. Heart 2002; 87: 67-69.
51. Chang AC, Huhta JC, Yoon GY, Wood DC, Tulzer G, Cohen A, Mennuti M, Norwood WI. Diagnosis, transport, and outcome in fetuses with left ventricular outflow tract obstruction. J Thorac Cardiovasc Surg 1991; 102: 841-848.
52. Satomi G, Yasukochi S, Shimizu T, Takigiku K, Ishii T. Has fetal echocardiography improved the prognosis of congenital heart disease? Comparison of patients with hypoplastic left heart syndrome with and without prenatal diagnosis. Pediatr Int 1999; 41: 728-732.
53. Verheijen PM, Lisowski LA, Stoutenbeek P, Hitchcock JF, Brenner JI, Copel JA, Kleinman CS, Meijboom EJ, Bennink GBWE. Prenatal diagnosis of congenital heart disease affects preoperative acidosis in the newborn patient. J Thorac Cardiovasc Surg 2001; 121: 798-803.
54. Eapen RS, Rowland DG, Franklin WH. Effect of prenatal diagnosis of critical left heart obstruction on perinatal morbidity and mortality. Am J Perinatol 1998; 15: 237-242.
55. Kumar RK, Newburger JW, Gauvreau K, Kamenir SA, Hornberger LK. Comparison of outcome when hypoplastic left heart syndrome and transposition of the great arteries are diagnosed prenatally versus when diagnosis of these two conditions is made only postnatally. Am J Cardiol 1999; 83: 1649-1653.
56. Jacobs ML, Norwood Jr WI. Fontan operation: Influence of modifications on morbidity and mortality. Ann Thorac Surg 1994; 58: 931-944.
57. Mahle WT, Clancy RR, Moss EM, Gerdes M, Jobes DR, Wernovsky G. Neurodevelopmental outcome and lifestyle assessment in school-aged and adolescent children with hypoplastic left heart syndrome. Pediatrics 2000; 105: 1082-1089.
58. Meberg A, Ottestad JE, Freland G, Hals J, Sörland SJ. Early clinical screening of neonates for congenital heart defects: the cases we miss. Cardiol Young 1999; 9: 169-174.
59. Abu-Harb M, Hsy E, Wren C. Death in infancy from unrecognised congenital heart disease. Arch Dis Child 1994; 71: 3-7.
60. Ainsworth SB, Wyllie JP, Wren C. Prevalence and clinical significance of cardiac murmurs in neonates. Arch Dis Child Fetal Neonatal Ed 1999; 80: 43-45.
61. Sands A, Craig B, Mulholland C, Patterson C, Dornan J, Casey F. Echocardiographic screening for congenital heart disease: a randomized study. J Perinat Med 2002; 30: 307-312.
62. Koppel RI, Druschel CM, Carter T, Goldberg BE, Mehta PN, Talwar R, Bierman FZ. Effectiveness of pulse oximetry screening for congenital heart disease in asymptomatic newborns. Pediatrics 2003; 111: 451-455.
63. Reich JD, Miller S, Brogdon B, Casatelli J, Gompf TC, Huhta JC, Sullivan K. The use of pulse oximetry to detect congenital heart disease. J Pediatr 2003; 142: 268-272.
64. Sharland GK, Allan L. Screening for congenital heart disease prenatally. Results of a 21/2-year study in the South East Thames Region. Br J Obstet Gynaecol 1992; 99: 220-225.